Anti-hepatitis B virus activities of astragaloside IV isolated from Radix Astragali

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 1, 2009, Pages 132-135

  Wang, Shuguang ^a   Li, Jiyang ^b   Huang, Hai ^b   Gao, Wen ^a   Zhuang, Changlong ^a   Li, Bo ^a   Zhou, Pei ^b   Kong, Deyun ^a  

^a China swzlym onlineshcn   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Anti hepatitis B virus activity; Astragaloside IV; Radix Astragali

Indexed keywords

ASTRAGALOSIDE IV; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; SAPONIN; TRITERPENOID; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CHINESE HERB; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; DUCKLING; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B VIRUS; HUANGQI; HUMAN; HUMAN CELL; NONHUMAN; RADIX ASTRAGALI; SOUTHERN BLOTTING; TREATMENT DURATION; VIRUS INHIBITION;

ANIMALS; ASTRAGALUS PLANT; CARCINOMA; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; DUCKS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B VIRUS, DUCK; HUMANS; SAPONINS; TRANSFECTION; TRITERPENES;

EID: 59949089860     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.132     Document Type: Article

References (15)

1. Szmuness W., Prog. Med. Virol., 24, 40-69 (1978).
2. Maupas P., Goudeau A., Coursaget P., Chiron J. P., Drucker J., Barin F., Perrin J., Denis F., Diop-Mar I., Summers J., "Viruses in Naturally Occuring Cancer," Cold Spring Harbor Laboratory, Cold Spring Harbor, 1980, pp. 481-506.
3. Perrillo R. P., Semin. Liver Dis., 25, 20-28 (2005).
4. Qi L. W., Yu Q. T., Li P., Li S. L., Wang Y. X., Sheng L. H., Li Y., J. Chromatogr. A, 1134, 162-169 (2006).
5. Zhang W. J., Hu F. P., Binder B. R., Johann W., Thromb. Haemost., 90, 904-914 (2003).
6. Zhang Y. Y., Zhu H. Y., Huang C. G., Cui X. L., Gao Y. J., Huang Y., Gong W. F., Zhao Y., Guo S. S., J. Cardiovasc. Pharmacol., 47, 190-195 (2006).
7. Zhang J., Chen J. Z., Zhang J. P., Jia X., Jiang W. F., J. Fourth Mil. Med. Univ., 28, 2291-2293 (2007).
8. He Z. Q., Findlay J. A., J. Nat. Prod., 54, 810-815 (1991).
9. Sells M. A., Chen M. L., Acs G., Proc. Natl. Acad. Sci. U.S.A., 84, 1005-1009 (1987).
10. Tim M., J. Immunol. Methods, 65, 55-63 (1983).
11. Jibert A. R., Wu T. T., England J. M., J. Virol., 66, 1377-1388 (1992).
12. Shin M. S., Kang E. H., Lee Y. I. K., Antiviral Res., 67, 163-168 (2005).
13. Freiman J. S., Jilbert A. R., Dixon R. J., Holmes M., Gowans E. J., Burrell C. J., Wills E. J., Cossart Y. E., Hepatology, 8, 507-513 (1988).
14. Zou Y. H., Yang Y., Wu Q., Acta Universitatis Medicinalis Anhui, 38, 267-269 (2003).
15. Wang C. Y., Giambrone J. J., Smith B. F., J. Clin. Microbiol., 40, 2544-2549 (2002).